Your shopping cart is currently empty

GSK_WRN3 acts as a selective inhibitor of the WRN protease with an IC 50 of 8.6 μM. It demonstrates significant selectivity by covalently binding to the Cys727 residue of the WRN protein. By inhibiting WRN protease activity, GSK_WRN3 hinders the growth of MSI tumor cells by increasing DNA double-strand breaks and inhibiting cell proliferation [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | GSK_WRN3 acts as a selective inhibitor of the WRN protease with an IC 50 of 8.6 μM. It demonstrates significant selectivity by covalently binding to the Cys727 residue of the WRN protein. By inhibiting WRN protease activity, GSK_WRN3 hinders the growth of MSI tumor cells by increasing DNA double-strand breaks and inhibiting cell proliferation [1]. |
| Molecular Weight | 352.40 |
| Formula | C16H20N2O5S |
| Cas No. | 2923009-50-9 |
| Smiles | OC1=C(NC(=O)C(C(N[C@@H]2C=CS(=O)(=O)C2)=O)=C1)C3CCCCC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.